2Adler A I,Stevens R J,Manley S E,et al.Development and progression of nephropathy in type 2 diabetes:the United Kingdom Prospective Diabetes Study(UKPDS 64)[J].Kidneyt Int,2003,63(1):225-232.
3Brenner B M,Cooper M E,de Zeeuw D,et al.Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy[J].N Engl J Med,2001,345(12):861-869.
4Chan J C,Wat N M,So W Y,et al.Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes.An Asian perspective from the RENAAL study[J].Dabetes Care,2004,27(4):874-879.
6The ADVANCE Collaborative Group.Intesive biood glucose control and vascular outcomes in patients with type 2 diabetes[J].N Engl J Med,2008,358(24):2 560-2 572.
7Mogensen C E.Managenment of early nephropathy indi-abetic padents[J].Annu Rev Med,1995,46(67):79-81.
8Karadeniz MM,Erdogan MA,et al.Short-term effects ofirbesartan treatment on microalbuminuria in patients withnormotensive type 2 diabetes.Saudi Med J,2008,29(10):1414-1418.
9K. A. Fawcett,N. J. Wareham,J. Luan,H. Syddall,C. Cooper,S. O’Rahilly,I. N. M. Day,M. S. Sandhu,I. Barroso.PARL Leu262Val is not associated with fasting insulin levels in UK populations[J]. Diabetologia . 2006 (11)
10K. Walder,L. Kerr-Bayles,A. Civitarese,J. Jowett,J. Curran,K. Elliott,J. Trevaskis,N. Bishara,P. Zimmet,L. Mandarino,E. Ravussin,J. Blangero,A. Kissebah,G. R. Collier.The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes[J]. Diabetologia . 2005 (3)
